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Abstract
White matter (WM) microstructural declines have been demonstrated in Alzheimer’s disease and
amnestic mild cognitive impairment (aMCI). However, the pattern of WM microstructural
changes in aMCI after controlling for WM atrophy is unknown. Here, we address this issue
through joint consideration of aMCI alterations in fractional anisotropy, mean diffusivity, axial
diffusivity, and radial diffusivity, as well as macrostructural volume in WM and gray matter
compartments. Participants were 18 individuals with aMCI and 24 healthy seniors. Voxelwise
analyses of diffusion tensor imaging data was carried out using tract-based spatial statistics
(TBSS) and voxelwise analyses of high-resolution structural data was conducted using voxel
based morphometry. After controlling for WM atrophy, the main pattern of TBSS findings
indicated reduced fractional anisotropy with only small alterations in mean diffusivity/radial
diffusivity/axial diffusivity. These WM microstructural declines bordered and/or were connected
to gray matter structures showing volumetric declines. However, none of the potential
relationships between WM integrity and volume in connected gray matter structures was
significant, and adding fractional anisotropy information improved the classificatory accuracy of
aMCI compared to the use of hippocampal atrophy alone. These results suggest that WM
microstructural declines provide unique information not captured by atrophy measures that may
aid the magnetic resonance imaging contribution to aMCI detection.
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INTRODUCTION
Alzheimer’s disease (AD) has well-established neurodegenerative effects on cerebral gray
matter (GM) [1, 2]. However, there is pathological evidence that AD also affects cerebral
white matter (WM) microstructure [3, 4]. The advent of magnetic resonance diffusion tensor
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imaging (DTI) has made it possible to explore AD-based WM microstructural alterations in
vivo. DTI is sensitized to the random motion of water molecules as they interact within
tissues, thus reflecting characteristics of their immediate structural surroundings at a
nominal 50 micron scale. Two of the most commonly used indices of WM microstructural
integrity are fractional anisotropy (FA) and mean diffusivity (MD). Decreased FA is thought
to reflect a reduction in axonal structure/coherence, demyelination, small vessel alterations,
and degradation of microtubules [5, 6]. MD is thought to represent an overall measure of
cellular integrity, with increases reflecting a loss of both neurons and glia [5, 6].
Reduced FA and/or increased MD has been observed in AD and its typical prodromal state
of amnestic mild cognitive impairment (aMCI) [7], and even in cognitively normal seniors
at high AD-risk [8]. However, it is unknown whether these WM microstructural declines
provide unique information from measures of gross tissue atrophy in aMCI. An increased
understanding in this area may be of future clinical relevance because aMCI has been shown
to represent early-stage AD in the majority of cases that have come to autopsy or have been
followed longitudinally to the point of transition to clinical dementia [9–11]. Increased
understanding of the neurobiological bases of WM integrity declines in aMCI may help
guide the development of new targets for interventions intended to slow or prevent transition
to AD. In addition, if WM integrity markers provide unique biologic information distinct
from that provided by measures of cerebral atrophy, then these markers may improve the
diagnostic prediction of aMCI and/or conversion from aMCI to AD.
Knowledge about whether WM microstructural declines provide unique information from
measures of gross tissue atrophy in aMCI would benefit from consideration of: 1) WM
macrostructural atrophy; 2) GM macrostructural atrophy; and 3) the four main metrics of the
diffusion tensor [FA, MD, axial diffusivity (DA), and radial diffusivity (DR)]. WM
microstructural declines have been shown to be strongly correlated with WM atrophy [12,
13]. It is thus important to identify WM microstructural changes not attributable to
macrostructural WM atrophy. Because WM atrophy tends to be relatively circumscribed in
aMCI, it should be possible to include WM atrophy information in DTI analyses in order to
identify WM microstructural changes that are not attributable to WM atrophy. To our
knowledge, no aMCI studies to date have controlled for WM atrophy in DTI analyses.
After controlling for WM atrophy, information about the nature of remaining WM
microstructural declines could then be gained through joint consideration of FA/MD/DR/
DA. In particular, exploring the patterns of overlap of MD/DR/DA with regions of reduced
FA can provide more information about the neurobiological bases of WM integrity than the
separate exploration of these metrics of the diffusion tensor [14, 15]. For example, regions
showing decreased FA and overlapping increases in MD and/or decreases in DA are thought
to reflect gross tissue loss [16], while those showing decreased FA and overlapping
increases in DR are suggestive of reduced myelin integrity [17]. In contrast, FA reductions
not solely driven by either DA or DR changes alone may reflect a subtle mixture of damage
to axonal structures and the surrounding myelin sheath [15, 16].
The goals of the this study were: 1) to show whether DTI-based patterns of diffusivity can
be identified that are not attributable to WM atrophy in aMCI; 2) to assess potential
relationships between WM microstructural declines and GM atrophy; and 3) to determine
whether the addition of WM integrity information improves the classificatory accuracy of
aMCI participants compared to the classificatory accuracy achieved from using hippocampal
GM alone.
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MATERIALS AND METHODS
Participants
The research procedures were approved by the Institutional Review Board of the University
of Kentucky Medical Center, and all participants provided informed written consent.
Participants were community-dwelling individuals who were right-handed, with normal or
corrected-to-normal visual acuity, and were recruited from the University of Kentucky
Alzheimer’s Disease Center (UK-ADC) longitudinal normal volunteer cohort. Inclusion
criteria for this cohort are minimum 65 years of age, cognitive and neurological normality at
enrollment, agreement to brain donation to the UK-ADC at death, a designated informant for
structured interviews, and willingness to undergo annual examinations. Participants were
excluded from the cohort if they had a history of substance abuse (including alcohol), major
head injury (a head injury resulting in loss of consciousness for which the patient was
hospitalized), major psychiatric illness (e.g., bipolar disorder, major depression, or
schizophrenia), medical illnesses that are unstable (requiring other than routine follow-up
and medical management) and/or have an effect on the central nervous system (e.g.,
encephalitis, meningitis, stroke, multiple sclerosis, epilepsy, Parkinsonism, or other
neurologic disease). The annual evaluation includes a comprehensive, standardized
neuropsychological battery prescribed by the NIA-Alzheimer’s Disease Centers National
Alzheimer’s Coordinating Center Uniform Data Set (http://www.alz.washington.edu/).
Participants in the present study were 24 healthy seniors (HS) without cognitive impairment
and 18 seniors with aMCI (Table 1). None of the participants had uncontrolled
hypercholesterolemia, hypertension, or diabetes. The HS and aMCI groups did not differ in
age [t(34) = 0.23, p = 0.91]. The two groups also did not differ in gender distribution [χ2 (1)
= 0.83, p = 0.76] or mean number of years of education [t(24) = 0.61, p = 0.86]. All
individuals receiving a diagnosis of aMCI met the following criteria: 1) a Clinical Dementia
Rating (CDR) total score of 0.5, with a CDR box score of at least 0.5 for memory; 2) a
documented memory complaint; and 3) a score 1.5 SD below their prior annual assessment
on the Wechsler Memory Scale total memory score and Consortium to Establish a Registry
for AD (CERAD) word list delayed recall. All participants in the present study were scanned
within three months of their diagnosis as HS or aMCI.
Magnetic Resonance Imaging (MRI) Acquisition Procedures
Data were collected on a 3 Tesla Siemens TIM scanner at the University of Kentucky, using
an 8-channel head array coil. Whole-brain diffusion tensor images (40 contiguous 3 mm
thick axial slices) were acquired with 36 non-collinear encoding directions (b = 1000 sec/
mm2) using a double spin echo EPI sequence and the following parameters: repetition time
= 6900 ms, echo time (TE) = 105 ms, flip angle = 90°, acquisition matrix = 128 × 128, field
of view = 224 mm, in-plane resolution = 1.75 × 1.75 mm voxels). Five images were
acquired without diffusion weighting (b = 0 sec/mm2, b0). In addition, a double-echo
gradient-echo sequence (TE1 = 5.19 ms, TE2 = 7.65 ms) with slice position and spatial
resolution matching those of the EPI acquisition was used to map the spatial inhomogeneity
of the B0 field.
Whole-brain structural imaging was performed using a three-dimensional magnetization-
prepared rapid gradient echo (MP-RAGE) sequence and the following parameters: repetition
time = 2100 ms, TE = 2.93 ms, inversion time = 1100 ms, flip angle = 12°, field of view =
224×256×192 mm, sagittal partitions, yielding isotropic 1 mm3 voxels.
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MRI Analysis Procedures
Structural preprocessing—Preprocessing and analyses of anatomic structural images
were carried out via voxel-based morphometry (VBM), using the statistical parametric
mapping software package (SPM5, http://www.fil.ion.ucl.ac.uk/spm) implemented in
Matlab 6.5 (Math Works, Natick, MA). Preprocessing of images included segmentation,
bias correction, and spatial normalization, incorporated into a single generative model [18].
MRIs were segmented into GM, WM, and cerebrospinal fluid (CSF) images using SPM5
prior probability templates [18]. GM and WM images were normalized to their own custom
templates in the standard space of the Montreal Neurological Institute (MNI) T1-weighted
template using a set of non-linear basis functions. A modulation step was also incorporated
into the preprocessing model in order to explore regional differences in absolute volume.
Intracranial volume was estimated as the sum of GM, WM, and CSF volume for each
participant (for use as a nuisance covariate in subsequent statistical analysis). As a final
preprocessing step, all normalized, modulated, GM and WM images were smoothed using
an 8 mm FWHM isotropic Gaussian kernel.
Structural voxelwise analysis—The preprocessed GM/WM data were analyzed within
the framework of the general linear model. Statistical parametric maps of between-group
(HS compared to aMCI) differences in GM/WM volume were determined using a full-
factorial model (a two-sample t-test) with unequal variance and age, gender, and intracranial
volume as nuisance covariates. Second-level, group linear contrasts were then conducted on
parameter estimates from the model. The voxel values for the contrasts constituted a
statistical parametric map (SPM) of the t statistic. Differences between groups were assessed
using a statistical threshold of p<0.05 (family-wise error corrected for multiple
comparisons).
DTI preprocessing—DTI data was pre-processed and analyzed using the Functional MRI
of the Brain (FMRIB) software library (FSL v4.1.5). Raw images were pre-processed to
correct for motion and residual eddy current distortion using a 12-parameter affine
alignment to the corresponding b0 image via FMRIB’s Linear Image Registration Tool
(FLIRT: http://www.fmrib.ox.ac.uk/fsl). Images were then corrected for static field
inhomogeneity distortions using B0 field maps. Next, FMRIB’s Diffusion Toolbox (FDT
v2.0) was used to fit the diffusion tensor and calculate eigenvalues, FA, MD, DA, and DR.
Registration of FA images into MNI152 space and subsequent voxelwise analyses followed
a series of procedures known as Tract-Based Spatial Statistics (TBSS v1.2;
http://www.fmrib.ox.ac.uk/fsl/tbss/) [19], as described in detail in our previous work [20,
21]. Briefly, all subjects’ FA images were aligned to a common target using a nonlinear
registration approach, and FA datasets were then affine registered and resampled to 1 × 1 ×
1 mm MNI152 space.
MNI-transformed FA images were then averaged to generate a mean FA image that was
used to create a common WM tract skeleton. The skeleton is thinned so that it represents the
center of all tracts common to the group and then thresholded at an FA value of 0.2 in order
to minimize partial volume effects after warping across subjects. Each participant’s aligned
FA image was subsequently projected onto the FA skeleton in order to account for residual
misalignments between participants after the initial nonlinear registration. Each subject’s
MD, DA, and DR maps in MNI space were then projected onto the common tract skeleton
using the pipeline for non-FA data provided by TBSS, which employs the projection vectors
from each individual’s FA-to-skeleton transformation [19].
DTI voxelwise analyses—The FA/MD/DR/DA analyses included WM atrophy as a
covariate to address the issue of dependence of the diffusivity effects on WM atrophy.
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Voxelwise statistical analyses were performed via a permutation-based inference for
nonparametric statistical thresholding using FSL’s “randomize” [22]. Between group
comparisons of FA/MD/DR/DA values within the tract skeleton were tested using a two-
sample t-test. Nuisance covariates were age, gender, and normalized WM volume in the two
regions of interest (ROIs) showing WM atrophy: the right cingulum and left temporal WM.
A permutation nonparametric test (using the maximum number of 5000 permutations) was
employed using a threshold-free cluster enhancement in order to avoid the use of an
arbitrary threshold in the initial cluster formation. Results were then thresholded at p < 0.05
(corrected for multiple comparisons).
In addition to the separate analyses of FA/MD/DR/DA, to characterize the neurobiological
bases of significant FA declines in the aMCI group, a second set of analyses were run in
which MD, DR, and DA statistical maps were masked by regions showing significant FA
reductions. Anatomical locations of significant clusters were detected using the Johns
Hopkins University WM tractography atlas and the International Consortium of Brain
Mapping-DTI white matter labels atlas.
Structural and DTI correlation analyses—Several criteria were considered in an
attempt to focus on biologically meaningful comparisons and to maximize power to detect
potential relationships between WM microstructure and GM volume. First, ROIs were
centered on clusters showing GM/WM reductions in the aMCI group in the VBM/DTI
voxelwise analyses. This approach is likely to provide more power than the use of a priori
ROIs of entire tracts/gyri, which could miss potential relationships by averaging across
‘intact’ and ‘diseased’ portions of large structures. Second, because DTI voxelwise results
revealed aMCI declines in FA (with minimal declines in MD, DR, or DA), correlation
analyses focused on potential FA-volume relationships. Third, correlations explored
potential relationships between WM tracts and GM structures with established connections
based on previous work [23–25]. Based on these criteria, a total of nine correlations were
between FA and GM volume. The correlations were between bilateral cinguli (CING) and
their corresponding hippocampi; the left CING and left parahippocampal gyrus; bilateral
uncinate fasciculi (UNC) and their corresponding hippocampi; left UNC and left
parahippocampal gyrus; the splenium (SPL) and bilateral precunei; and the left superior
longitudinal fasciculus (SLF) and left lateral parietal cortex.
For both volumetric and FA data, ROI masks consisted of a three-dimensional area
including all contiguous voxels showing significance in the HS > aMCI voxelwise statistical
map. Structural volumetric (GM and WM) ROI masks were generated using the WFU
Pickatlas [26]. Volumetric ROI masks were applied to each subject’s smoothed, normalized,
modulated GM/WM images, and ROI-masked volumes (the sum of the voxels’ intensities
within that ROI multiplied by voxel volume) were then computed for each subject. All
volumetric ROI volumes were ‘normalized’ (divided by intracranial volume), providing an
estimate of atrophy in that ROI. Diffusion (FA) ROI masks were created from significant
clusters using FSL’s ‘fslmaths’. Masks were then applied to each subject’s FA images using
FSL’s ‘fslmeants’ to extract mean FA in that ROI.
Receiver Operating Characteristic Analyses
Receiver operating characteristic (ROC) curves were generated from logistic regression
models with group (aMCI versus HS) as the dependent variable by calculating the area
under the curve (AUC). Model 1 explored the classificatory accuracy of mean FA across
bilateral posterior CING. Model 2 explored the classificatory accuracy of mean normalized
volumes across bilateral hippocampi. Model 3 explored the classificatory accuracy of the
combination of models 1 and 2.
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RESULTS
Voxel-Based Morphometry
Figure 1 presents the results from the group comparisons of WM and GM volume. The
aMCI group showed WM volumetric reductions in the right CING and left temporal lobe
(panel A). GM volumetric reductions were observed in bilateral portions of the hippocampal
complex, left parahippocampal gyrus, bilateral portions of the precuneus, and left lateral
parietal cortex (panels B and C). The largest cluster of reduced GM volume in the aMCI
group was primarily located in the left precuneus, although its peak effect was within the
right precuneus (4 –56 16; 107 voxels).
White Matter Microstructural Integrity
Figure 2 presents the results from the group comparisons of FA and MD after controlling for
WM atrophy. The anatomic underlay is the MNI152 standard brain. The aMCI group
showed decreased FA (shown in red) compared to the HS group in a number of regions,
prominently including portions of the CING, the SPL, and SLF in the parietal lobes;
portions of the inferior longitudinal fasciculus (ILF) in the temporal lobe; and portions of the
UNC in the frontal lobe. Within these regions of decreased FA, there was only one region of
increased MD in the aMCI group (shown in orange): an anterior portion of the CING. There
were no regions in which the HS group showed decreased FA or increased MD compared to
the aMCI group.
Figure 3 (top panel) presents the results from the comparison of component diffusivities (DR
and DA) that overlap with regions showing lower FA in the aMCI group. There were only a
few regions in which FA declines in the aMCI group were driven solely by DR or DA.
Regions of decreased FA showing increased DR in the aMCI group (shown in blue) were
portions of the anterior limb of the internal capsule and the CING. Regions of decreased FA
showing decreased DA in the aMCI group (shown in yellow) were restricted to small
portions of the corticospinal tracts. Finally, there were no regions in which the aMCI group
showed increased DA.
Figure 3 (bottom panel) presents the results from the voxelwise comparison of DR and DA
that did not overlap with regions showing lower FA in the aMCI group. There were only a
few regions showing altered component diffusivities in the aMCI group. Regions showing
increased DR were small portions of the CING, UNC, and ILF. Regions showing decreased
DA in the aMCI group were portions of the corticospinal tracts and the SLF. There were no
regions in which the aMCI group showed increased DA.
Correlation Analyses
Regression scattergrams of FA versus GM volume are presented in Figure 4. None of the
nine potential relationships was significant at a family-wise significance threshold of p <
0.006 (0.05 divided by 9 comparisons). Even when a liberal significance threshold of p <
0.05 (uncorrected) was employed, only one out of nine potential relationships was
significant: FA in the SPL and volume in the left precuneus [F = 5.1, p = 0.038]. In contrast,
there was no relationship between FA in the SPL and volume in the right precuneus [F =
0.69 p = 0.42]. There was no relationship between FA in the left SLF and volume in the left
lateral parietal region [F = 0.93 p = 0. 35]. There were no relationships between FA in the
left/right CING and volume in the left/right hippocampi (both p’s≥0. 39). There were no
relationships between FA in the left/right UNC and volume in the left/right hippocampi
(both p’s≥0. 36). There were no relationships between FA in the left CING or left UNC and
volume in the left parahippocampal gyrus (both p’s≥0. 78).
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In contrast, and as expected, the two potential relationships between FA and WM volume
were significant at a family-wise significance threshold of p < 0.025 (0.05 divided by 2
comparisons). FA in the right CING and volume in the right CING were significantly
correlated [r (16) = 0.65, p = 0.003]. In addition, FA in the left temporal lobe ROI and
volume in the left UNC were significantly correlated [r (16) = 0. 59, p = 0.009].
Receiver Operating Characteristic Analyses
The AUC for the models of each measure is presented in Figure 5. The AUC was 0.75 for
the model of mean FA in bilateral CING. The AUC was 0.77 for the model of mean
normalized volume in bilateral hippocampi. When FA in the CING and volume in the
hippocampi were combined into a single model, discriminatory accuracy increased to 0.91.
DISCUSSION
There were three main findings of the present study related to the nature of WM
microstructural declines in aMCI. First, WM microstructural changes not attributable to WM
atrophy were characterized primarily by reduced FA, with smaller changes in MD and
component diffusivities (DR/DA). Second, reductions in the microstructural integrity of
WM tracts were relatively independent from atrophy in connected GM structures. Third, FA
was found to provide unique information compared to GM atrophy in discriminating aMCI
from HS. Classification accuracy in this study increased from AUC 0.77 using hippocampal
volume alone to 0.91 when CING FA was added to this volumetric GM information. The
details of these findings are discussed below.
The VBM analysis demonstrated WM atrophy in the right CING and left temporal lobe. The
relatively circumscribed WM atrophy in aMCI is consistent with previous reports, although
atrophy in portions of the corpus callosum has also been observed in previous aMCI studies
[27–28]. As expected, WM volumetric declines were correlated and FA declines in the right
CING and left temporal lobe. WM volumetric declines were thus included as nuisance
covariates in DTI analyses to identify WM integrity changes not detectable with
conventional volumetric MRI. GM volumetric reductions were more extensive than WM
volumetric declines. Specifically, GM atrophy was observed in bilateral hippocampi, left
parahippocampal gyrus, bilateral precunei, and left lateral parietal cortex, consistent with
previous reports of medial temporal and parietal GM atrophy in aMCI [29–31]. However,
unlike WM atrophy, GM reductions were not correlated with FA declines (discussed below).
After controlling for WM atrophy, joint consideration of the major components of the
diffusion tensor revealed several patterns of WM integrity changes in the aMCI group. A
predominant pattern was reduced FA in the absence of differences in MD, DA, or DR.
Regions showing decreased FA in the aMCI group in the absence of alterations in MD, DA,
or DR included portions of the CING, UNC, SPL, ILF, and SLF. In contrast, only a few
WM tracts showing decreased FA in the aMCI group showed overlapping alterations in MD,
DA, or DR. We also explored the possibility of altered component diffusivities in the aMCI
group outside of regions of decreased FA. Once again, only a few WM tracts showed
alterations in component diffusivity. Taken together, this pattern of diffusivity results
suggest that WM integrity changes in aMCI reflect a subtle mixture of axonal and myelin
damage, possibly resulting from minor loss of fibers and their surrounding myelin sheath
[15,16].
Many of the GM regions showing atrophy were those bordering and/or connected to WM
tracts showing microstructural declines. For example, the medial temporal lobe regions
showing atrophy (hippocampus and parahippocampal gyrus) connect to the posterior
cingulate cortex via caudal portions of the CING [23], which showed reduced WM integrity
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in the present results. However, none of the nine potential relationships between WM
integrity and volume in connected GM structures was significant when controlling for
multiple comparisons. Even when a more liberal significance threshold of p < 0.05
(uncorrected) was employed, only one out of nine potential relationships was significant.
This pattern of weak correlations was observed despite the attempt to maximize power for
this analysis by centering ROIs on clusters showing peak WM/GM reductions in the aMCI
group in the voxelwise analyses.
In the other eight potential GM volume-FA relationships tested, correlations were weak (r’s
between 0.11 – 0.28) and did not even approach an uncorrected significance threshold. In
addition, there were no increases in MD or DA in these WM tracts. These data are
inconsistent with a view that WM integrity tract reductions are merely a secondary
consequence of GM degeneration in aMCI. Our results in aMCI contrast with those in AD,
where positive correlations between FA/MD and GM volume have been reported [32–36].
Relatively less is known about the relationship between WM integrity reductions and GM
atrophy in aMCI, with some recent studies reporting a relationship and others reporting no
relationship [34, 37, 38]. There are several possible reasons for the different correlation
results observed in the present aMCI study and previous AD studies. One possibility is that
GM atrophy and WM integrity reductions may be differentially sensitive to classic AD
pathological features (i.e., amyloid plaques and neurofibrillary tangles) early in the disease
process. A second possibility is that classic AD pathologies may progress at different rates
within cerebral GM and WM. A third possibility is that DTI declines in aMCI reflect other
as yet unknown pathologies more specifically related to WM. Future studies should test
between these possibilities by correlating FA with AD-related CSF analytes such as Aβ1–42
and phosphorylated tau (P-tau181), as well as with other analytes reflecting the integrity of
myelin (e.g., myelin basic protein), inflammatory mediators, and protein/protein complexes.
In addition, future studies should explore the cerebral biochemical correlates of WM
integrity changes in early AD states through correlations between FA declines and MR
spectroscopy measures of metabolite ratios reflecting various molecular and cellular
processes.
Results from ROC classification analyses suggest that combining WM integrity and GM
atrophy information improves classification of aMCI. The model that explored FA in
bilateral CING ROIs differentiated the aMCI and HS groups with 75% accuracy, which was
similar to the accuracy of 77% achieved for the model which explored structural volumes in
bilateral hippocampi. However, when DTI and volumetric parietal ROIs were combined into
a single model, discriminatory accuracy increased to 91%. This finding complements our
correlation results, again suggesting that WM integrity reductions and atrophy in connected
structures provide complementary rather than redundant information in aMCI. However, we
interpret the high classificatory accuracy of the combined DTI-volumetric model cautiously
because our study was cross-sectional and had a relatively small sample size. Future
research will be required to determine the predictive accuracy of similar combined WM
integrity/GM atrophy models in predicting conversion from aMCI to AD.
We note several caveats of the present study. First, the cross-sectional design does not allow
for assessment of the relative timing of GM atrophy and WM integrity declines. Second,
correlation analyses focused on FA because minimal alterations were observed in other
diffusivity measures, limiting power for potential correlations between these measures and
GM volume. Future studies will be required to assess potential relationships between MD/
DR/DA and volumetric reductions in connected structures. Third, as with all cross-sectional
studies of aMCI, we are not yet able to confirm that all aMCI participants will develop AD.
It should be noted that subtle impairment in executive function, as observed in the present
aMCI group, have been reported even in pure aMCI and tend to be predictive of future AD
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[39]. In addition, most individuals with a clinical diagnosis of aMCI at our center show AD
pathology [40]. Nevertheless, it is not yet possible to know what percentage of the present
aMCI or normal samples harbor significant AD pathology. This issue should be addressable
in the future because participants in the longitudinal normal cohort study at our ADRC have
agreed to brain donation at death.
In conclusion, our results identify WM microstructural declines in aMCI that cannot be
appreciated by conventional measures of WM atrophy. In general, FA declines were
characterized by a pattern of decreased DA and increased DR (rather than more selective
changes in one component diffusivity), suggesting reductions in both axonal and myelin
integrity in aMCI. The lack of correlation between WM microstructural declines and atrophy
in connected GM structures justifies future research intended to understand the relationship
between WM integrity and CSF analytes representing classic AD pathology and other
pathologies which may be more specifically related to WM. Finally, adding WM integrity
information to classic AD medial temporal lobe atrophy models may improve prediction of
AD and this issue should be explored in future longitudinal studies.
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Figure 1.
Volumetric reductions in aMCI. Regions of significantly smaller volume in the aMCI group
compared to the HS group are displayed after controlling for global intracranial differences.
A) WM volumetric differences highlighting a cluster in the right cingulum (crosshair) are
displayed on the canonical MNI T2 template. B) GM volumetric differences highlighting a
cluster within the right hippocampus (crosshair) are displayed on the canonical MNI T1
template. C) The full set of GM volumetric differences are displayed on SPM’s single
subject, 3D rendered surface. Note: CING, cingulum; LTP, left temporal; LPC, left parietal
cortex; PCN, precuneus; HPC, hippocampal complex; PHG, parahippocampal gyrus.
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Figure 2.
Alterations in FA and MD in aMCI after controlling for WM atrophy. The anatomic
underlay used for illustration is the MNI152 T1-weighted 1mm brain. The registered
average FA skeleton is represented in green. Regions of decreased FA in the aMCI group
are displayed in red. Regions of increased MD that overlap decreased FA in the aMCI group
are displayed in orange. The numbers below coronal sections represent y coordinates in
MNI space. Note: CING, cingulum; UNC, uncinate fasciculus; SLF, superior longitudinal
fasciculus; ILF, inferior longitudinal fasciculus; SPL, splenium.
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Figure 3.
Alterations in component diffusivities in aMCI after controlling for WM atrophy. The
anatomic underlay and registered average FA skeleton are described in the Figure 1 legend.
The top panel displays regions of increased in DR (blue) or decreased in DA (yellow) that
overlap with regions of decreased FA (red) in the aMCI group. The bottom panel displays
regions of increased DR (blue) or decreases in DA (yellow) that do not overlap with regions
of decreased FA in the aMCI group. The numbers below coronal sections represent y
coordinates in MNI space. Note: ALIC, anterior limb of the internal capsule; CING,
cingulum; CST, corticospinal tracts; UNC, uncinate fasciculus; SLF, superior longitudinal
fasciculus; ILF, inferior longitudinal fasciculus.
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Figure 4.
The relationship between WM integrity and GM atrophy in aMCI. Regression plots display
FA against normalized GM volume in nine regions. Each diamond represents one of the 18
MCI participants. *Significant at p < 0.05, uncorrected.
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Figure 5.
Receiver operator characteristic (ROC) curves. ROC curves plot the sensitivity on the y-axis
against 1-specificity on the x-axis. Lines at 45 degree angles tangent to the ROC curve mark
the best cutoff point under the assumption that false negatives and false positives have
similar costs. The ROC curves correspond to models of (A) mean FA across bilateral CING,
(B) mean normalized GM volume across bilateral hippocampi, (C) a combined FA and
volumetric model. The highest classificatory accuracy was obtained for the combined FA
and volumetric model (AUC = 0.91).
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Table 1
Subject demographics and neuropsychological scores.
aMCI HS
Mean S.D. Mean S.D.
Age 77.1 5.8 77.9 7.1
Education 15.83 2.6 16.21 2.4
Gender 8 m/10 f 11 m/13 f
Clinical Dementia Rating 0.5 0
Mini Mental State Exam 27.1* 1.3 28.4 1.1
Wechsler Memory Scale 24.8* 5.9 31.6 6.2
CERAD Word list delayed 4.9* 2.5 6.9 1.4
Digit Span Forward 4.9 1.1 5.3 1.3
Digit Span Backward 4.1 1.3 4.4 1.6
Digit Symbol 58.6 12.4 51.4 11.8
Trails A 49.6 16.7 41.3 15.7
Trails B 109.3* 39.2 91.2 26.6
Boston Naming Test 23.2 2.9 25.3 3.1
Geriatric Depression Scale total score 1.6 2.3 1.4 1.1
Functional Activities Questionnaire total score 2.1 2.2 1.1 1.4
*
p < 0.05 statistical significance between the amnestic mild cognitive impairment (aMCI) and healthy senior (HS) groups.
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